Home > Boards > US OTC > Miscellaneous >

Innovest Global Inc. (IVST)

Add IVST Price Alert      Hide Sticky   Hide Intro
Moderator: jedijazz, LivinLarge8, tbattaglia
Search This Board: 
Last Post: 1/23/2019 11:32:22 AM - Followers: 45 - Board type: Free - Posts Today: 2




A Group of Like-Minded
Individuals all Working
Toward a Common Goal


To operate our business responsibly on a daily basis to maximize shareholder value and be a source of strength to our companies, helping them reach their fullest potential.

We work with our companies to increase long-term corporate value for all of our shareholders through the implementation of our Source of Strength Doctrine. This program is focused on assisting IVST companies to strengthen their competitive advantage and increase their profitability, while enabling them to achieve operational excellence and enhanced customer satisfaction.

We Value Our: Shareholders

Business owners who want the best practices and liquidity that Innovest offers to make their dreams a reality; whether those dreams are taking sales to the next level, or getting top-dollar for a business they’ve put their heart and soul into, we have clear proposals to make those dreams a reality.

We Value Our: Companies

Our family of companies are created specifically, or acquired purposefully to deliver on our mission. Most importantly, Innovest provides the sales and marketing influence that grows revenue. This means no outsourcing of any of the required elements for the success of building and delivering the products and services Innovest supports.

We Value Our People

At Innovest Global we understand that assets create value. That's why we regard our people as our most valuable asset. We have created a culture of putting the highest degree of care into our people—from leadership to staff to shareholders. It's our belief that without them we cannot achieve success, regardless of company or industry type.


A publicly traded operating company with diversified holdings in Commercial & Industrial, Energy, and Biotechnology & Health Services.


Growth and Value are our primary objectives. Being a Conglomerate gives investors the opportunity to own stock in a company that is diversified. Diversification reduces risk. Reduced risk, in a high growth environment, where profits are reinvested for growth rather than paid out as dividends.


A Source of Strength for our participating companies. A strong company, that’s healthy and growing, is in the best interests of Innovest shareholders. We do everything we can to strengthen, serve, and grow our participating companies. Whether novel technologies, or well established operations, we are a resource for strength.


Dan Martin

Chairman, Chief Executive Officer

Mr. Martin is an accomplished C-level executive with success driving results across a broad base of middle-market companies. He has earned a reputation for creating business models that are able to efficiently acquire customers while providing significant levels of compensation to independent distributors, for using technology to enhance results, and for efficiently managing efforts to be on time and cost effective. His primary expertise is understanding the needs of growing organizations, evaluating and defining the strategic objectives of a business, and communicating with stakeholders to successfully execute company objectives. Mr. Martin has led the initiative to generate both organic and acquisition based sales in upstart environments on multiple occasions.


Mike Yukich

Chief Financial Officer

Mr. Yukich served as Chief Financial Officer and Controller for Eaton’s Truck Component Operations in the 1990’s, which was a $1.5 billion enterprise with 8500 employees in North and South America. Mr. Yukich was responsible for all the financial and information technology functions. He led the due diligence and integration team for the acquisition of a $200 million Brazilian transmission supplier that was totally integrated within one year of acquisition. 

After Eaton, Mr. Yukich served as Senior Vice President and Chief Financial Officer for Guide Corporation, a $600 million Tier one automotive supplier for external lighting systems. At Guide, Mr. Yukich was a key management team member, that took a former General Motors division and created a stand- alone company. He oversaw a $20 million investment for IT conversion and improved quality programs. In cooperation with the equity owners, Mr. Yukich secured another $22 million for a new manufacturing facility in Mexico and an engineering and technical center for R & D, as well as ongoing engineering and other corporate functions.

Mr. Yukich holds a BA degree in business administration from the University of Mount Union and an MBA from Central Michigan University. He has been an active member and past officer and director of the Financial Executives Institute for the past twenty-two years. His community involvement includes serving as President of the Beta Iota House Corporation of Sigma Nu National fraternity, an affiliate of the University of Mount Union. Mr. Yukich also served in the United States Navy on two warships (USS Shadwell LSD-15 and USS Inchon LPH-12).


Damon Mintz

President - Commercial & Industrial Division

Mr. Mintz has an extensive track record of successfully building and growing businesses in multiple industries including Energy, Internet / Software and Health Services. After completing his college studies he started his first business, which acquired approximately 50,000 residential, and small commercial energy customers, and generated over $30 million per year in energy revenues. Since then he has owned and consulted for commercial & industrial companies ranging from midsized, to a multi-billion dollar public company, and most recently founded the single source procurement, management, and energy efficiency company which is now the foundation of the Innovest Energy Group. Mr. Mintz is well known for his ability to develop a vision for the business, execute the right strategy to succeed, and leading the team to operate at their highest level of performance. His functional expertise includes business development, sales, marketing and external business growth initiatives such as mergers and acquisitions. He understands that no matter what industry you are in, people are the greatest asset of the business, and helping them reach their fullest potential is Mr. Mintz’s greatest strength.


Dwain Morris-Irvin, PhD, MPH

President - Biotech & Health Services Division

Dr. Morris-Irvin is an active participant in many Biotechnology and Health Science endeavors, and is an expert including patent generation in such areas as treatments for Parkinson’s, brain cancer, and even cosmetic application of advanced bioscience. He is also an expert in the physical operations of laboratories, and hospitals. He received his PhD from UCLA School of Medicine, and Masters in Public Health from UCLA School of Public Health, and trained at The Wallenberg Neuroscience Center at Lund University in Lund, Sweden. He was also a Professor, Faculty member at Cedars-Sinai Medical Center, Department of Neurosurgery.

Dr. Morris-Irvin’s PhD is in Pharmacology and Developmental Neuroscience with an emphasis on neural stem cell fate and differentiation. His research focused on neural development and Notch Signaling in mammalian neural stem cells. He also worked as an NIH/NINDS Post-Doctoral Fellow in Dr. Anders Bjorklund laboratory in Lund, Sweden. There, his focus was on research projects that investigated the potential role of cell replacement therapy for patients with Parkinson’s disease. They developed several protocols for the efficient generation of dopaminergic neurons from forebrain and ventral midbrain stem and progenitor cells.

Additionally, Dr. Morris-Irvin led research investigations in the role of adaptive immunity in Parkinson’s disease. He also developed two patents in the area of immunotherapy for brain tumor patients, specifically Glioblastoma Multiforme (GBM). His research team focused on molecular mechanisms that impart therapeutic resistance in cancer cells, including cancer stem cells. They utilized this data to develop novel immunotherapies for brain tumor patients.


Jason Painley

Independent Member of The Board of Directors

Mr. Painley was an Examiner and Accounting Policy Specialist for the Federal Reserve Bank of Cleveland From 2001 to 2011, with responsibilities at the national Federal Reserve System level. While there, he was charged with monitoring, analyzing, interpreting, and proactively addressing a wide variety of factors related to ensuring that financial institutions were operating in a safe manner, and in compliance with banking laws and regulations. He also led onsite examinations of institutions ranging from small, to over $250 billion assets, and worked constructively with financial institution executives and boards of directors.

Since then, until recently he was Senior Vice President and Chief Risk Officer of Park National Corporation (NYSE: PRK), which has over $7 billion in assets and employs nearly 2,000 associates. His job spanned all functional areas of the bank, and was to constantly evolve a risk- aware culture in order to avoid, proactively minimize, and immediately address all forms of potential and manifested risks, financial and otherwise. Now, he has taken on greater functional responsibility becoming the Chief Financial Officer of Ohio based Mechanics Bank.


John Klopp

Independent Member of The Board of Directors

Mr. Klopp is Chief Executive Officer, of the second-generation firm Klopp Investment Management headquartered in Cleveland, OH. The firm is a large-cap, blue chip platform fund, which is available to Klopp clients and trust accounts directly, and others through their financial advisors and investment platforms. Their balanced blue chip strategy of investing in large companies, has averaged 13.8% growth per year 2009-2017.

He received an MBA from Baldwin Wallace College, then worked in New York City and for many years was responsible for inter Broker-Dealer transactions, then Compliance, Trading, Research, Asset Allocation, and Portfolio Management. He is a member of the Cleveland Society of Security Analysts and is active in the Chartered Financial Analysts program.


We Provide Support for
the Most Dedicated &
Thoughtful Founders

Innovest Global's Commercial & Industrial Division is made of a group of companies which provide best-in class products and services to the commercial and industrial market.

Guidance Today for a Brighter Tommorrow.

Shepherd Energy Solutions (SES) is an innovative energy services company that offers a unique approach to reducing businesses overall energy costs. For more than 20 years SES and its Principals have saved thousands of customers money by lowering their costs on their current energy consumption as well as significantly reducing the amount of energy they consume.

Shepherd Energy Solutions
8456 E Washington St, 2nd Floor
Chagrin Falls, OH 44023
The new LED lights in our warehouse have made a huge difference in the quality and brightness of light. The improvement in lighting is only overshadowed by the significant reduction in our electric bill.

Ohio's First Independent Energy Broker

H. P. Technologies, Inc. was founded in 1984 as an engineering and general contracting company specializing in the reconstruction of industrial furnaces and ovens. Efficiency and/or productivity increases using less energy were our project goals. In 1993, the company became Ohio's first independent energy broker. Now, 25 years after pioneering the deregulated energy sales profession, the company is taking a page out of its history and providing more diversified energy services and programs by assisting clients become more prudent in their use of energy.

H.P. Technologies, Inc.
5505 Detroit Rd., Suite E
Sheffield Village, OH 44054

Your leading supplier of personal protection equipment, apparel and safety supplies, from head to toe!

Chagrin Safety Supply, Inc. is the leading supplier of personal protection equipment and apparel from head to toe. Serving the Medical, Dental, Industrial and Construction Industries.

Chagrin Safety Supply
8227 E Washington St
Chagrin Falls, OH 44023
I would recommend Chagrin Safety Supply to anyone who is serious about implementing an effective, no-hassle first-aid supply program.

Inbound and Outbound Call Services

Contact Source Solutions offers inbound and outbound call services. We customize every project to your needs and don’t try and fit your project into a standard call center set up. In 2015 we were awarded the JD Power “Outstanding Customer Service” award for one of our clients.

Contact Source Solutions, LLC
8456 E Washington St, 2nd Floor
Chagrin Falls, OH 44023

Share Structure

Market Cap
Authorized Shares
Outstanding Shares
Shareholders of Record  



Innovest Global Provides August Shareholder Update with Milestones Including Patent Approval, Biotech Progress, Financial Achievements

CLEVELAND, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Innovest Global Inc. (OTC Markets: IVST) (the “Company” or “Innovest”), a Conglomerate with operations in commercial and industrial products and services, and biotechnology, today announced notable financial progress, and having launched its Biotechnology & Health Services Division with significant achievements.

The Innovest Biotech Division launched with the acquisition of a twenty percent stake in StemVax Therapeutics, and with the news that the primary technology for the StemVax brain tumor vaccine had been granted patent approval after a nine year filing process. Immediately following this news, StemVax was granted exclusive worldwide rights from Cedars-Sinai Medical Center to this patent and three other technologies it will now use in its efforts to commercialize the vaccine.

Other notable July events include:

  • Winslow Asset Management, the first institutional investor in Innovest Global, filed showing that they remain long shareholder
    First half 2018 revenue growth 55.8%
    Current assets of $877,861
    Cash balance of $561,062
    Unchanged free-trading float of 11,796,710 common shares
    No convertible debts, no warrants or options outstanding
    Headcount is now 44 employees
    Stock performance up 930% on the year (as of Friday August 10th, 2018 close).
    Commercial & Industrial Division generated July monthly revenue of $351,763
    The previously announced $650K+ Fortune 500 contract for providing call center services to Byram Healthcare Division was fully implemented, team trained and operational; “The Innovest team is highly professional, does an incredible job for us at the right price, and takes our business as seriously as we do,” said Perry Bernocchi, Chief Executive Officer of Byram Healthcare. “To our customers, they are part of the Byram team, and they’ve proven we can rely on them to be a proud part of our family.”
    Advanced an acquisition initiative on a top priority target, kept others in discussion, and finalized our second half plan


More about StemVax Therapeutics:

StemVax Therapeutics is a Translational Biotechnology Company that develops novel therapies for brain tumor patients. We focus our efforts on developing immunotherapeutic approaches to treating patients with Glioblastoma Multiforme (GBM), a devastating brain cancer. We also focus our research efforts on novel drug development to target Cancer Stem cells and other multi-resistant cancer cells. We seek to make a difference in patient’s lives. Bringing new beginnings to the market by developing novel therapeutics. Dr. Dwain Morris-Irvin, President of Innovest’s Biotech division is the StemVax founder and Chief Science Officer.

Cedars-Sinai Medical Center is a non-profit hospital and academic health science center located in Los Angeles, California. They employ over 2,000 physicians and are considered one of the top hospitals and research organizations in the world. Dr. Irvin previously was one of their key contributors in the areas of research that he founded StemVax to pursue. 

Innovest Global Commercial & Industrial Division Update, Featuring Another Significant Contract and Continued Growth

CLEVELAND, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Innovest Global Inc. (OTC Markets: IVST) (the “Company” or “Innovest”), a Conglomerate with operations in commercial and industrial products and services, and biotechnology, sold its most recent six-figure revenue contract last week, and notes that its Call Center is now generating double the baseline revenue it was generating just a few months ago, when it was acquired. The division is now pacing $4.5 million in annual revenue.

“Sally Emch, our President of Call Center Operations, has doubled the center’s baseline revenue since the acquisition, and the Shepherd team just closed another six figure sale at the end of last week,” said Dan Martin, CEO of Innovest. “The StemVax patent approval has been a recent focus of excitement, and our C&I Group is also really hitting stride. Working together well, closing big competitive sales, and excited to push through the quarter with momentum. The team is so excited at the support our shareholders have shown, and the enthusiasm is something I wish everyone could see.”

The Company maintains an unchanged free-trading float of 11,796,710 common shares with no convertible debts, no warrants or options outstanding. After several days of gains including a high of $.3175, the stock price pulled back 7.93% on Friday to close at $0.27, up 28.5% since the $0.21 open price last Monday, and up over 1,000% on the year.

The Innovest C&I Division is diligently refining organic growth strategies. “Innovest is in discussions with meaningful acquisition targets, but those transactions only work long-term if we can grow them and help them succeed – and so far I couldn’t be more impressed with Division President Damon Mintz, Sally Emch, Bill Oler, Dennis Giancola and the rest of our 40 people who are doing an incredible job right now,” said Mr. Martin. His comments are echoed by the Innovest mission statement, which is, “To operate our business responsibly on a daily basis to maximize shareholder value and be a source of strength to our companies, helping them reach their fullest potential.”

Innovest Twitter: https://twitter.com/InnovestGlobal


Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#1774  Sticky Note IVST CLoses Acquisition of Authority National Supply tbattaglia 11/05/18 09:46:19 AM
#1667  Sticky Note The Board of ‘Authority National Supply’ Approves Pending LivinLarge8 10/22/18 07:11:02 PM
#1640  Sticky Note $ IVST Innovest Global Inc. (OTCMARKETS:IVST) Closes Audit, Signs jedijazz 10/19/18 10:44:22 AM
#2113   Correction? it’s been flat forever Gizzer211 01/23/19 11:32:22 AM
#2112   Big correction coming LivinLarge8 01/23/19 10:32:15 AM
#2111   Well said :) totally agree! stayinin 01/15/19 02:00:43 PM
#2110   IVST can not stay under the radar much ProfitScout 01/15/19 01:59:45 PM
#2109   Greatest otc company on the radar, Just a stayinin 01/10/19 04:17:00 PM
#2108   IVST management clearly knows their business and they ProfitScout 01/10/19 03:22:39 PM
#2107   Haven't looked lately but the company never uses stayinin 01/10/19 02:50:02 PM
#2106   Innovest Global Signs Letter of Intent to Acquire ProfitScout 01/10/19 09:32:54 AM
#2105   What is the total o/s and a/s of Harbor6460 01/10/19 01:15:12 AM
#2104   This is one slow mover but I'm glad stayinin 01/09/19 03:06:04 PM
#2103   The comments from CEO Dean Martin in last ProfitScout 01/07/19 11:32:01 AM
#2102   IVST - Great success story in motion - Gman1122 01/07/19 10:27:54 AM
#2100   Note the statement in this week's IVST news ProfitScout 01/03/19 03:50:18 PM
#2099   Nice news this should be .50+ LivinLarge8 01/02/19 11:56:53 AM
#2098   Innovest Energy Group Wins $1 Million Contract to ProfitScout 01/02/19 09:10:29 AM
#2097   Big 2019 coming LivinLarge8 01/02/19 09:10:20 AM
#2096   .479 falling LivinLarge8 12/31/18 01:46:38 PM
#2095   Yes, IVST is set up very nicely for ProfitScout 12/31/18 10:49:50 AM
#2094   Just hold tight. Up-listing coming any day now tbattaglia 12/30/18 06:42:34 PM
#2093   IVST is a great growing company but when stayinin 12/28/18 01:09:47 PM
#2092   $IVST way undervalued .479 up now this should LivinLarge8 12/28/18 01:05:52 PM
#2091   Innovest has now completed seven transactions to round LivinLarge8 12/27/18 03:08:02 PM
#2090   Reload time at .30 LivinLarge8 12/27/18 12:30:10 PM
#2089   IVST management has accomplished so much in 2018 ProfitScout 12/26/18 10:10:45 AM
#2088   Innovest Global Acquires Midwest Curtainwalls, Adding $10 Million ProfitScout 12/24/18 09:57:52 AM
#2087   Should IVSTs Dan Martin be ranked as one ProfitScout 12/21/18 09:38:40 AM
#2086   that's news? appreciate the enthusiasm. dshade 12/21/18 08:37:17 AM
#2085   It's not hard to see how easily IVST ProfitScout 12/20/18 05:33:51 PM
#2084   Super thin to .65 LivinLarge8 12/17/18 10:12:29 AM
#2083   They’ve had a pretty ridiculous year I remember LivinLarge8 12/17/18 09:47:45 AM
#2082   Redundant, but thanx! stayinin 12/17/18 09:39:48 AM
#2081   Nice news out today LivinLarge8 12/17/18 09:38:43 AM
#2080   Good, comprehensive update from IVST for us today. ProfitScout 12/17/18 09:19:16 AM
#2079   $ IVST Innovest Global Provides December Shareholder Update Featuring jedijazz 12/17/18 08:29:12 AM
#2078   Did they get the 2018 audits done and/or stayinin 12/14/18 01:28:08 PM
#2077   How long has MICA been here? stayinin 12/14/18 01:20:44 PM
#2076   The Innovest Global Biotech Division is a particularly ProfitScout 12/12/18 10:44:36 AM
#2075   The IVST growth story of acquisition, partnership, new ProfitScout 12/11/18 10:00:19 AM
#2074   $17,000 bid at .44 LivinLarge8 12/10/18 11:20:51 AM
#2073   Nice news huge bud at .44 LivinLarge8 12/10/18 10:44:26 AM
#2072   Could see a quick move up on this jedijazz 12/10/18 09:55:43 AM
#2071   Looking at Level 2 growth as the Bid jedijazz 12/10/18 09:55:16 AM
#2070   Another important development that adds even higher notability ProfitScout 12/10/18 09:37:45 AM
#2069   Innovest Global Biotech Partners with Preeminent Los Angeles Association jedijazz 12/10/18 09:13:58 AM
#2068   IVST 's newly acquired Midwest Curtainwalls is a $12 jedijazz 12/07/18 02:09:39 PM
#2067   22k bid at .44 spread is tight breakout coming LivinLarge8 12/07/18 12:18:33 PM
#2066   Yeah it's one of the better OTC stocks jedijazz 12/07/18 12:05:35 PM
#2065   You don't find many OTC issues at this ProfitScout 12/07/18 10:14:24 AM
#2064   Overlooked and undervalued with $34 million in revenue jedijazz 12/06/18 03:51:13 PM
#2063   Innovest Global Signed an LOI to Acquire Midwest jedijazz 12/06/18 03:11:58 PM